Eterna Therapeutics
ERNA
#10317
Rank
โ‚ฌ8.51 M
Marketcap
1,08ย โ‚ฌ
Share price
-2.29%
Change (1 day)
-69.82%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): -68,90ย โ‚ฌ

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -65,01ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -106,66ย โ‚ฌ an increase over its 2021 EPS that were of -704,65ย โ‚ฌ.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-68,90ย โ‚ฌ
2022-106,66ย โ‚ฌ-84.86%
2021-704,65ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Baxter
BAX
-0,56ย โ‚ฌ-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-0,10ย โ‚ฌ-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-1,71ย โ‚ฌ-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
3,14ย โ‚ฌ-104.83%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Techne
TECH
0,42ย โ‚ฌ-100.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
0,53ย โ‚ฌ-100.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel